Intuitive Surgical (ISRG)

Healthcare · Medical Instruments & Supplies · S&P 500
$404.76 -0.42% on the day Market cap $146.4B 52-week range $328.57 to $603.88 Prices as of Oct 7, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Free cash flow growth the price needs
19% a year for 10 years

At a market value of $146.4B, Intuitive Surgical's free cash flow of $2.5B (fiscal 2025) would need to grow about 19% a year for the stock to be worth today's price. That is faster than the company has grown its free cash flow over the last 9 years.

Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from Intuitive Surgical's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.

Implied by the price19.2% a year
Free cash flow, last 9 years10.3% a year
Revenue, same period15.7% a year
Price to free cash flow58.8x

Fundamental grade

B

Five factors scored 1 to 9 from ISRG's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation2
Profitability9
Growth8
Financial health9
Cash efficiency9

Key numbers

P/E (trailing)50.4x
P/E (forward)39.8x
Price / free cash flow58.8x
EV / EBITDA38.3x
Price / sales13.3x
Price / book8.35x
Revenue growth+18.5%
Operating margin31.3%
Net margin28.4%
Return on equity17.3%
Dividend yield—
Debt / equity0.14x

Results from SEC filings

Fiscal years, from Intuitive Surgical's 10-K filings. The deep dive has 15+ years, quarters and every line.

Fiscal year20212022202320242025
Revenue$5.7B$6.2B$7.1B$8.4B$10.1B
Net income$1.7B$1.3B$1.8B$2.3B$2.9B
Free cash flow$1.7B$958M$750M$1.3B$2.5B
EPS (diluted)$4.66$3.65$5.03$6.42$7.87
Operating margin31.9%25.3%24.8%28.1%29.3%

Where the revenue comes from

Revenue by products, fiscal 2025.

Instruments and accessories$6.0B60%
Systems$2.5B25%
Service$1.6B16%

Superinvestors who own ISRG

From each investor's latest 13F filing (what a 13F shows). 7 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Hersh Cohen
ClearBridge Investments
Trimmed $483M0.40%Q2 2026
Philippe Laffont
Coatue Management
Trimmed $316M0.65%Q2 2026
Cliff Asness
AQR Capital Management
Added $134M0.05%Q2 2026
Ron Baron
Baron Capital (BAMCO)
Trimmed $37M0.06%Q2 2026
Joel Greenblatt
Gotham Asset Management
Added $10M0.02%Q2 2026
Mario Gabelli
GAMCO Investors
Added $6M0.05%Q2 2026
Eric Marshall
Hodges Capital Management
Trimmed $233,4380.02%Q2 2026

Insider buying

Open-market purchases by Intuitive Surgical's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

DateInsiderSharesPriceValue
Mar 23, 2026 Ro Khanna
0$478.04—
Mar 23, 2026 Ro Khanna
0$478.04—
Feb 24, 2026 Ro Khanna
0$494.02—
Feb 24, 2026 Ro Khanna
0$494.02—
Feb 5, 2026 Ro Khanna
0$476.32—
Feb 5, 2026 Ro Khanna
0$476.32—
Jan 30, 2026 Gilbert Ray Cisneros, Jr.
0$504.22—
Jan 30, 2026 Gilbert Ray Cisneros, Jr.
0$504.22—

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when ISRG trades at or below it.

$

Free accounts get 3 price alerts. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

What growth does Intuitive Surgical's stock price imply?

At a market value of $146.4B, Intuitive Surgical would need its free cash flow to grow about 19% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 9 years its free cash flow grew 10% a year.

Are Intuitive Surgical insiders buying the stock?

8 open-market insider purchases of ISRG in the last 12 months, from SEC Form 4 filings.

Which superinvestors own Intuitive Surgical?

7 of the superinvestors Investingly tracks hold ISRG in their latest 13F, including Hersh Cohen, Philippe Laffont, Cliff Asness.

Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.